Cannabis Foundations Session 3: Potential Harms of Medicinal Cannabis (2023) скачать в хорошем качестве

Cannabis Foundations Session 3: Potential Harms of Medicinal Cannabis (2023)

Dr. James MacKillop talks about the current research around the potential harms of medicinal cannabis. Recorded as a part of the Innovations in the Science of Cannabis Conference, October 2023. In this session, part of the Foundation Series, we dive deep into the risks and harms associated with cannabis use. From cannabis use disorder (CUD) to its impact on cognition, mental health, lung health, and even cannabinoid hyperemesis syndrome (CHS), this presentation provides a comprehensive overview of the potential downsides of cannabis. Dr. James MacKillop, a clinical psychologist and researcher, emphasizes the importance of balancing the potential medical benefits of cannabis with its risks, particularly for frequent or heavy users. Key topics include the neuroadaptive changes in the brain caused by chronic cannabis use, the reversible nature of cognitive impairments, and the dose-dependent relationship between cannabis use and adverse outcomes like psychosis and car crashes. Whether you're a medical professional, a cannabis user, or simply curious, this video offers valuable insights into the complex world of cannabis risks and harms. The discussion also highlights the importance of understanding cannabis use disorder, a psychiatric condition that affects a minority of users but can have significant consequences. The speaker explores the symptoms of CUD, including tolerance, withdrawal, and compulsive use, and discusses the lack of pharmacological treatments currently available. Additionally, the video touches on the association between cannabis use and other mental health conditions, such as anxiety, depression, and psychosis, as well as the potential risks to lung health and the mysterious cannabinoid hyperemesis syndrome. By the end of the session, you'll have a clearer understanding of the risks and how they scale with frequency and potency of use. The presentation concludes with a balanced perspective on the overall risk profile of cannabis compared to other substances like alcohol and tobacco. While cannabis is not without its risks, the evidence suggests that its harms are generally less severe than those associated with other legally available substances. However, the speaker stresses the importance of informed decision-making, particularly for medical cannabis users, to minimize the potential for adverse outcomes. This video is a must-watch for anyone interested in the science behind cannabis, its effects on the brain and body, and the ongoing debate about its risks and benefits. ___________________________________________________________ • Cannabis use disorder (CUD) • Risks of cannabis • Cannabis and cognition • Cannabis and mental health • Cannabinoid hyperemesis syndrome (CHS) • Cannabis and lung health • Cannabis withdrawal symptoms • Cannabis and psychosis • Medical cannabis risks • Cannabis and car crashes • High THC cannabis effects • Cannabis addiction treatment • Cannabis and ADHD • Cannabis and anxiety • Cannabis and depression ___________________________________________________________ The Michael G. DeGroote Centre for Medicinal Cannabis Research is a multidisciplinary leader in medicinal cannabis research. The Centre is led by the Michael G. DeGroote School of Medicine Initiative for Innovation in Healthcare at McMaster University in Hamilton, Ontario, Canada. This initiative leverages McMaster University’s world-renowned expertise in health research and evidence-based medicine to create a hub for evidence-based data and innovative research. https://cannabisresearch.mcmaster.ca/